-
Symbol
-
LCTX on NYSE
-
Investment type
-
Equity / Common shares
-
Latest Disclosed Shares Owned
-
57,848,357 shares
-
Security Ownership %
-
23%
NEAL C. BRADSHER ownership in Lineage Cell Therapeutics, Inc. Common shares (LCTX)
14 Nov 2025 - NEAL C. BRADSHER has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 57,848,357 shares of Lineage Cell Therapeutics, Inc. Common shares (LCTX).
This represents 23% ownership of the company.
In their previous filing dated 28 Jan 2025, BROADWOOD PARTNERS, L.P. had reported owning 57,848,357 shares, indicating a new holding.